See also this year's filing and all EDGAR filings for this company.
PDF Report 0000949699_2015_Pharmacyclics_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000949699, Pharmacyclics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,015,559,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 8,730,000 |
| 2 | PropertyPlantAndEquipmentNet | 32,476,000 |
| 3 | remainder_Assets | 3,342,000 |
| 4 | LiabilitiesCurrent | 194,236,000 |
| 5 | LiabilitiesNoncurrent | 1,821,000 |
| 6 | remainder_Liabilities | 34,885,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 195,877 |
| 9 | ResearchAndDevelopmentExpense | 608,865,044 |
| 10 | remainder_Expenses | 1,277,333,039 |
| 11 | remainder_Revenues | 3,078,463,999 |
| 12 | remainder_NetIncome | -792,504 |
| 13 | remainder_ComprehensiveNetIncome | -2,104 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,060,107,000 |
| 1 | Liabilities | 230,942,000 |
| 2 | Expenses | 1,886,393,960 |
| 3 | Revenues | 3,078,463,999 |
| 4 | StockholdersEquity | 829,165,000 |
| 5 | NetIncome | 1,191,277,535 |
| 6 | ComprehensiveNetIncome | 1,191,276,483 |
| 7 | BaseVar | 3,128,350,784 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 4.65 |
| 9 | EconomicCapitalRatio | 4.90 |